Comprehensive Structure–Activity Relationship of Triantennary<i>N</i>-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
Thazha P. Prakash(Ionis Pharmaceuticals (United States)), Punit P. Seth(Ionis Pharmaceuticals (United States)), Eric E. Swayze(Ionis Pharmaceuticals (United States)), Hans Gaus(Ionis Pharmaceuticals (United States)), Sheri Booten(Ionis Pharmaceuticals (United States)), Sebastien A. Burel(Ionis Pharmaceuticals (United States)), Michael E. Østergaard(Ionis Pharmaceuticals (United States)), Susan Murray(Ionis Pharmaceuticals (United States)), Audrey Low(Ionis Pharmaceuticals (United States)), Michael T. Migawa(Ionis Pharmaceuticals (United States)), Armand Soriano(Ionis Pharmaceuticals (United States)), Jill Hsiao(Ionis Pharmaceuticals (United States)), Todd Machemer(Ionis Pharmaceuticals (United States)), Mariam Aghajan(Ionis Pharmaceuticals (United States)), Alfred E. Chappell(Ionis Pharmaceuticals (United States)), Jinghua Yu(Tianjin University), Patrick Cauntay(Ionis Pharmaceuticals (United States)), Recaldo L. Carty(Ionis Pharmaceuticals (United States)), Karsten Schmidt(Ionis Pharmaceuticals (United States)), Mark J. Graham(Ionis Pharmaceuticals (United States)), Jeff Crosby(Ionis Pharmaceuticals (United States)), Garth A. Kinberger(Ionis Pharmaceuticals (United States)), Guillermo Vasquez(Ionis Pharmaceuticals (United States)), Heather Murray(Ionis Pharmaceuticals (United States))
Cited by 131
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice
|Nucleic Acids Research|2014|594
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
|New England Journal of Medicine|2015|526
Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit
|Molecular and Cellular Biology|1998|524
Targeting APOC3 in the Familial Chylomicronemia Syndrome
|New England Journal of Medicine|2014|492